1066
Dr Pradip Chakrabarti

Dr Pradip Chakrabarti

16+ Years Experience
FRCSEd (UK), FACS (USA), FICS (USA) | Transplant Surgery
English
Overall Rating
Apollo Multispecialty Hospitals
# No. 58, Canal Circular Road, West Bengal, India, Kolkata - 700 054 Ph:91 33 2320 3040/2122, , Kolkata, ,

Select Date

    > Loading available days...

Available Slots:

    Overview

    Dr Pradip Chakrabarti is a distinguished Transplant Surgery based at Apollo Multispecialty Hospitals. With an impressive 16 years of experience in the medical field, he has dedicated his career to providing exceptional healthcare services to patients. He holds FRCSEd (UK), FACS (USA), FICS (USA), showcasing his extensive training and commitment to medical excellence. He is proficient in multiple languages, ensuring effective communication with a diverse range of patients.

    He is known for his patient-centric approach, emphasizing the importance of understanding each patient’s unique needs and medical history. He expertise encompasses a wide range of conditions related to Transplant Surgery, enabling he to deliver precise diagnoses and treatments. He ensures that patients receive care tailored to their individual health requirements.

    In his practice, Dr Pradip Chakrabarti goes beyond treatments by educating patients about their health conditions. This empowers individuals to take active roles in managing their health and making informed decisions. By fostering a supportive and understanding environment, he builds trust and ensures long-term health management strategies for patients.

    Dedicated to staying updated with advancements in his field, Dr Pradip Chakrabarti actively collaborates with other healthcare professionals to provide comprehensive care. He commitment to improving health outcomes continues to leave a lasting impact on the lives of his patients, solidifying his reputation as a trusted name in Transplant Surgery.

    Experience

    • Clinical Research Fellow, Dept. of Surgery / Biomedical Lasers and Spectroscopy.  University of Texas Medical Branch, Galveston, TX.
    • Clinical Fellow, Division of Transplantation University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    • Clinical Instructor, Department of Surgery & Consultant Surgeon, Division of Transplantation
    • University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    • Chief, Pancreas Transplantation & Consultant Surgeon, Renal and Pancreas Transplantation
    • Transplant Centre of Lehigh Valley, Lehigh Valley Hospital & Health Network, Allentown, PA, USA
    • Chief, Renal and Pancreas Transplantation Lehigh Valley Hospital, Allentown, PA, USA
    • Clinical Assistant Professor of Surgery, Penn State University College of Medicine, PA, USA
    • Consultant Transplant Surgeon, CK Birla Hospitals, CMRI, Calcutta, India

     

    Memberships

    • American Medical Association
    • The Transplantation Society, Montreal, Canada
    • American Society of Transplantation
    • American Society of Transplant Surgeons
    • International Pancreas and Islet Cell Transplantation Association
    • Pennsylvania Medical Association
    • British Transplant Society, London, UK
    • Royal College of Surgeons, Edinburgh, UK
    • American College of Surgeons, Chicago, USA
    • International College of Surgeons, Montreal, Canada
    • Vascular Access Society, Maastricht, Netherlands
    • Medical Advisory and Policy Board, Gift of Life Donor Program, Philadelphia, USA
    • Reviewer, Scientific Manuscripts for Transplantation and Am J Transplantation

    Awards

    • TELANGANA AND ANDHRA PRADESH STATE TOPPER.
    • BEST PAPER PRESENTATION AT TOS 2015 MEETING.

    Research and Publication

    • Corry RJ, Chakrabarti P, Shapiro R, Rao AS, Dvorchik I, Jordan ML, Scantlebury V, Vivas C, Fung JJ, Starzl TE.  Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.  Ann Surg, 230 (3): 372-81, 1999.
    • Chakrabarti P, Wong HY, Scantlebury VP, Jordan ML, Vivas C, Ellis D, Lombardozzi-Lane S, Hakala TR, Fung JJ, Simmons RL, Starzl TE, Shapiro R.  Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.  Transplantation, 70 (5): 760-64, 2000.
    • Jordan ML, Chakrabarti P, Luke P, Shapiro R, Vivas C, Scantlebury VP, Fung JJ, Starzl TE, Corry RJ.  Results of pancreas transplantation following steroid withdrawal under tacrolimus immunosuppression.  Transplantation, 69(2): 265-271, 2000.
    • Shapiro R, Jordan ML, Scantlebury VP, Vivas CA, McCauley J, Egidi MF, Randhawa P, Chakrabarti P, Corry RJ.  Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients – does dissynchronous rejection really exist?  Transplantation, 69(3): 440-01, 2000.
    • Chakrabarti P, Orihuela E, Egger N, Neal DE Jr., Gangula R, Adesokun A, Motamedi M.  Delta-aminolevulinic acid-mediated photosensitization of prostate cell lines: Implication for photodynamic therapy of prostate cancer. Prostate, 36(4): 211-18, 1998
    • Protsenko D, Torres JH, Chakrabarti P, Bell B, Orihuela E, Motamedi M.  Optical characterization and coagulation performance of side emitting fiber delivery systems for laser therapy of BPH: A comparative study. Urology, 47(6): 845-51, 1996.
    • Kim Beop-Min, Ostermeyer M, Jacques SL, Levy DA, Chakrabarti P, Torres JH, vonEschendach AC, Rastegar S, Motamedi M.  Transurethral fiber optics for in vivo optical property determination.  Proc SPIE 2681, Laser-Tissue interaction VII, San Jose 1996.
    • P. Chakrabarti, R. Shapiro, M.L. Jordan, V.P. Scantlebury, C. Vivas, R.J. Corry.  Surgical Complications of Enteric (ED) versus Bladder (BD) Drainage in Pancreas Transplantation.  Transplantation Proceedings, 33(1-2): 1647-1651, 2000.
    • Pradip Chakrabarti, Hsien Y Wong, Atsushi Toyofuku, Velma P. Scantlebury, Mark L Jordan, Carlos Vivas, Thomas Hakala, Richard Simmons, Thomas E Starzl, Ron Shapiro.  Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.  Transplantation Proceedings, 33(1-2): 1235-1236, 2000.
    • Agarwala S, Culligan E, Jain A, McCauley J, Shapiro R, Chakrabarti P, Burckart G.  Evaluation of renal function in transplant patients on chronic tacrolimus therapy.  J Clinical Pharmacology, 42: 798-805, 2002.
    • Luke PP, Herz DB, Bellinger MF, Chakrabarti P, Vivas CA, Scantlebury VP, Hakala TR, Jevnikar AM, Jain A, Shapiro R, Jordan ML. Long-term results of pediatric renal transplantation into a dysfunctional lower urinary tract. Transplantation 76(11) pp 1578-82.
    • 91st annual meeting of the American Urological Association – Orlando, May 4-9, 1996.  Torres JH, Chakrabarti P, Pow-Sang M, Orihuela E, Motamedi M.  High power directional diffusing fiber tip for rapid, uniform and deep photocoagulation of prostate.  J Urol 155: 705A, 1996.
    • XIVth Annual Houston Conference on Biomedical Engineering Research – Houston, February 8-9, 1996.  Motamedi M, Jacques SL, Chakrabarti P, Orihuela E.  Prostate response to photodynamic therapy.  Pp. 166.
    • 92nd annual meeting of the American Urological Association – New Orleans, April 12-19, 1997.  Chakrabarti P, Salas N, Herbert FB, Bender T, Gangula R, Motamedi M, Neal DE Jr.  Reduction of prostatic blood flow by finastride.  J Urol 157: 738A, 1997.
    • 75th Annual meeting of the South Central Section of the American Urological Association – Vail, Colorado, September 7-11, 1996.  Application of Delta-Aminolevulinic acid as a photosensitizer for the photodynamic therapy of prostate cancer (LNCaP and PC-3) cell lines.  Pradip Chakrabarti, Eduardo Orihuela, Massoud Motamedi, Durwood E. Neal Jr., Norman Egger, Adekunle Adesokun, Michael Warren.
    • 75th Annual meeting of the South Central Section of the American Urological Association – Vail, Colorado, September 7-11, 1996.  Mechanism of injury of photodynamic therapy in the canine prostate: A histopathological and electron microscopic study.  Pradip Chakrabarti, Eduardo Orihuela, Massoud Motamedi, Adekunle Adesokun, Daniel Cowan, Michael Warren.
    • The Annual Meeting of SPIE (International Society for Optical Engineers) – San Jose, January 27 - February 2, 1996.  Beop-Min Kim, Ostermeyer M, Jacques SL, Levy DA, Chakrabarti P, Torres JH, Rastegar S, vonEschenbach AC, Motamedi M.  Transurethral fiber optics for in vivo optical property determination.
    • 45th Annual Scientific Program of the Singleton Surgical Society – Galveston, Texas, April 12-13, 1996.  Pharmacokinetics and intracellular mechanism of injury of Delta-aminolevulinic acidmediated photodynamic therapy in prostate cancer cell lines.  P Chakrabarti, E Orihuela, M Motamedi, DE Neal JR, N Egger, A Adesokun, M Warren.
    • XXIII Congreso de la Confederacion Americana de Urologia – Santiago de Chile, Chile, September 28-October 2, 1996.  Source of PSA after cryotherapy of prostate cancer.  E Orihuela, P Chakrabarti, S Elfar, D E Neal Jr., E vanSonnenberg and M Warren.
    • Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.  Pradip Chakrabarti, Hsien Y Wong, Velma Scantlebury, Mark Jordan, Carlos Vivas, Demetrius Ellis, Susan Lombardozzi-Lane, Thomas R Hakala, John J Fung, Richard L Simmons, Thomas E Starzl, Ron Shapiro.  Thomas E Starzl Transplantation Institute, University of Pittsburgh.  Transplantation 1999; 67 (7): S 230.
    • Results of Pancreas Transplantation following steroid withdrawal under FK506 based immunosuppression.  Mark Jordan, Patrick Luke, Pradip Chakrabarti, Ron Shapiro, Velma Scantlebury, Carlos Vivas, Robert J Corry. Thomas E Starzl Transplantation Institute, University of Pittsburgh.  Transplantation 1999; 67 (9): S 567.
    • Association of bacterial and fungal infections with surgical complications in pancreas transplant recipients.  Shimon Kusne, Pradip Chakrabarti, Mohammad Akhavan-Heidari, Robert J Corry.  Transplantation 1999; 67 (7): S 174.
    • Outcome with mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation under tacrolimus based immunosuppression.  P Chakrabarti, R Shapiro, ML Jordan, V Scantlebury, C Vivas, RJ Corry. Pittsburgh, PA.  USA.  Pp. 140.
    • Outcome of enteric drainage (ED) versus bladder drainage (BD) in simultaneous pancreas-kidney transplantation.  Jeffrey Rogers, Pradip Chakrabarti, Ron Shapiro, Mark L Jordan, Velma P Scantlebury, Carlos A Vivas, Robert J Corry.  Pittsburgh, PA.  USA.  Pp. 56.
    • Renal allograft rejection with normal renal function in simultaneous kidney/pancreas recipients – does dissynchronous rejection really exist?  Ron Shapiro MD, Mark L Jordan MD, Velma P Scantlebury MD, Carlos Vivas MD, Jerry McCauley MD, Francesca Egidi MD, Parmjeet Randhawa MD, Pradip Chakrabarti MD, Robert J. Corry MD.  Pittsburgh, PA, USA.  Pp. 93.
    • Dendritic cells inhibit the allograft response.  Sheamus Teahan, Pradip Chakrabarti, Jane Mayotte, Rose Marie Hoffmann, Angus Thomson, Lina Lu, Mark Jordan.  Thomas E Starzl Transplantation Institute, University of Pittsburgh.  J Urol 161(4): 373A, 1999.
    • Surgical complications of enteric (ED) versus bladder (BD) drainage in pancreas transplantation.  Eldo E.  Frezza, Pradip Chakrabarti, Ron Shapiro, Mark L. Jordan, Velma P. Scantlebury, Carlos A. Vivas, Robert J. Corry.  Transplantation 2000; 69(8): S213.
    • Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression. Pradip Chakrabarti, Hsien YWong, Atsushi Toyofuku, Velma P. Scantlebury, Mark L. Jordan, Carlos Vivas, Thomas Hakala, Richard Simmons, Thomas E Starzl, Ron Shapiro. Transplantation 2000; 69(8): S224.
    • Surgical complications of enteric (ED) versus bladder (BD) drainage in pancreas transplantation.  P. Chakrabarti, R. Shapiro, M.L. Jordan, V.P. Scantlebury, C. Vivas, R.J. Corry.  Pp. 7.
    • Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.  Pradip Chakrabarti, Hsien Y Wong, Atsushi Toyofuku, Velma P. Scantlebury, Mark L Jordan, Carlos Vivas, Thomas Hakala, Richard Simmons, Thomas E Starzl, Ron Shapiro.  Pp. 332.
    • Dendritic cells inhibit the allograft response.  PPW Luke, S Teahan, SM Specht, P Chakrabarti, J Mayotte, R Hoffman, AW Thompson, L Lu, ML Jordan.  Pp. 250.
    • Results of pancreas transplantation following steroid withdrawal under tacrolimus-based immunosuppression. ML Jordan, P Chakrabarti, PPW Luke, R Shapiro, CA Vivas, VP Scantlebury, TR Hakala, S Fedorek, RJ Corry. Pp. 54.
    • Significance of elevated serum lipase as an indicator of rejection in pancreas transplantation.  Pradip K. Chakrabarti, Amitabh Gautam, Ron Shapiro, Shigetaka Inoue, Robert J. Corry.  Transplantation 2001; 71 (9): Abstract #1157.
    • Impact of cold ischemia time on allograft survival, function and surgical complications following pancreas transplantation.  Pradip K. Chakrabarti, Amitabh Gautam, Ron Shapiro, Robert J. Corry.  Transplantation 2001; 71 (9): Abstract #1158.
    • Use of rapamycin in pancreatic transplantation under tacrolimus based immunosuppression.  Ashok B. Jain, Velma P. Scantlebury, Victor Garrido, Pradip Chakrabarti, Ron Shapiro, Robert J. Corry.  Transplantation 2001; 71 (9): Abstract #309.
    • Deceased donor kidney transplantation without a prospective crossmatch (xmatch) in non-sensitized recipients. Pradip Chakrabarti, Bala Carver, Marjorie Williams, Michael Moritz. Am J Trans 2007, (Supl 2). 7, 158; Abstract # 45.
    • Virtual crossmatching: Effectiveness is dependent on all the anti-HLA specificities included in the analysis
      Cirocco, Robert E1; Kimble, Tricia1; Marilyn, Wetmore1; Mendoilina, Jen1; Disante, Kim1; Gilbert, Kristen1; Hartzel,Diane1;Chakrabarti,Pradip;and,Moritz,Michael. Am Soc Histocompatibility and Immunogenetics (ASHI) Abstracts presentation Nov 2009, San Francisco, USA.
    • Thymoglobulin induction therapy: Depletion levels of CD2/CD3 cells as a predictor of long term renal transplantation function. Robert Cirocco, PhD1, Tricia Kimbel1, Marj Williams1, Sonja Handwerk, RN1, Predip Chakrabarti,MD1 , Michael Moritz, MD. Am Soc Histocompatibility and Immunogenetics (ASHI) Abstracts presentation, Nov 2009, San Francisco, USA.
    • Virtual crossmatching effectiveness is dependent on all the anti-HLA specificities included. Cirocco,R., Kimble, T, Wetmore,M, Mendiolina,J, Disante,K, Gilbert,K, Hartzel, D, Chakrabarti, P and Michale Moritz, Human Immunology, Vol 70 ,sup 1,#P-6, pp14, Oct 2009.
    • Thymoglobulin induction therapy: Depletion level of CD2/CD3 cells as a predictor of long term renal transplant function. Cirocco,R.,Williams, M, Kimble, D, Chakrabarti, P and Michale Moritz. Human Immunology, Vol 70, sup 1, #115, pp69, Oct 2009

    List of Treatments

    • Rectum Cancer Treatment
    • Thyroid Cancer Treatment

    List of Conditions Treated

    • Breast Cancer
    • Brachydactyly
    • Gallbladder Cancer
    • Head and neck cancer
    • Oral Cancer

    Frequently Asked Questions

    Where does Dr. S. Chakravorty practice?

    Dr. S. Chakravorty's practice location is Metro Hospitals & Heart Institute, Sector 12. This hospital offers comprehensive cardiology and healthcare services.

    How can I schedule an appointment with Dr. S. Chakravorty?

    You can schedule an appointment with Dr. S. Chakravorty for an in-clinic visit by booking online. Please contact the hospital directly for scheduling assistance.

    Why do patients choose Dr. S. Chakravorty?

    Patients select Dr. S. Chakravorty for diabetes management, insulin-free treatment, and vaccinations/immunizations. These are key reasons for his patient appointments.

    What do patients say about Dr. S. Chakravorty?

    Dr. S. Chakravorty's experience is reflected in 22 patient recommendations and 17 shared experiences. Detailed patient feedback is available.

    What are Dr. S. Chakravorty's medical qualifications?

    Dr. S. Chakravorty holds an MBBS and an MD in General Medicine. Contact information for appointments is available through the hospital.

    What is Dr. S. Chakravorty's area of specialization?

    Dr. S. Chakravorty specializes in Internal Medicine and is a Consultant Physician.

    How many years of experience does Dr. S. Chakravorty have?

    Dr. S. Chakravorty has 33 years of experience in healthcare. His extensive medical background contributes to his expertise.

    Who is Dr. S. Chakravorty?

    Dr. S. Chakravorty is a Senior Consultant Physician and Diabetologist in Noida with 21 years of experience. His qualifications include MD (Medicine), FICP, FIACM, and a Diploma in Diabetes (UK). He serves as Unit Head of the Department of Internal Medicine, Diabetology, and Critical Care. He is also Editor-in-Chief of the Journal of Medicine of India, Joint-Secretary of the UP API Chapter, Chairman of the API Noida Chapter, a Founder member and Ex-Secretary of the API Noida Chapter, Organizational Secretary of UP APICON 2015, and Organizational Chairman of NOIDA APICON 2017 & 2018. Furthermore, he is a Faculty Member of the National RSSDI and a Principal & Co-Investigator in various research projects.

    Could not find the what you are looking for? 

    Request a Callback

    Image
    Image
    Image
    Doctor
    Book Appointment
    Book Appt.
    View Book Appointment
    Image
    Hospitals
    Find Hospital
    Hospitals
    View Find Hospital
    Image
    lab
    Book Health Checkup
    Health Checkup
    View Book Health Checkup
    Image
    Doctor
    Book Appointment
    Book Appt.
    View Book Appointment
    Image
    Hospitals
    Find Hospital
    Hospitals
    View Find Hospital
    Image
    lab
    Book Health Checkup
    Health Checkup
    View Book Health Checkup